Financhill
Back

ProShares UltraShort Nasdaq Biotech Vs. Ingevity Industry Stock Comparison

Sell
50

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
15.49
Seasonality Move:
-9.57%
Sell
15

NGVT
Ingevity

Last Price:
37.03
Seasonality Move:
10.62%
Sell
50
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?

  • The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $15.45. The Score for BIS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Ingevity (NGVT) is a Sell

Is Ingevity a Buy, Sell or Hold?

  • The current Ingevity [NGVT] share price is $37.04. The Score for NGVT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • NGVT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BIS Stock Price Chart

What is ProShares UltraShort Nasdaq Biotech's stock price today?

  • The ProShares UltraShort Nasdaq Biotech share price today is $15.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing slight selling pressure.

NGVT Stock Price Chart

What is Ingevity's stock price today?

  • The Ingevity share price today is $37.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGVT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 56.47 Buy
Chaikin Money Flow: -1832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.61 - 15.39) Buy
Bollinger Bands (100): (14.65 - 17.01) Sell

NGVT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 47.28 Sell
Chaikin Money Flow: 509201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 40.1) Sell
Bollinger Bands (100): (36.91 - 47.49) Sell

BIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.33 Buy
20-day SMA: 14.98 Buy
50-day SMA: 15.05 Buy
200-day SMA: 17.03 Sell
8-day EMA: 15.3 Buy
20-day EMA: 15.11 Buy
50-day EMA: 15.22 Buy
200-day EMA: 17.08 Sell

NGVT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.05 Sell
20-day SMA: 37.78 Sell
50-day SMA: 38.09 Sell
200-day SMA: 44.29 Sell
8-day EMA: 37.4 Sell
20-day EMA: 37.93 Sell
50-day EMA: 38.95 Sell
200-day EMA: 43.92 Sell

ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ingevity Earnings Growth & NGVT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.

ProShares UltraShort Nasdaq Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ingevity Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):